Skip to main content

Table 2 Main demographic and clinical characteristics of the study population

From: Tolerance to a new free amino acid-based formula in children with IgE or non-IgE-mediated cow’s milk allergy: a randomized controlled clinical trial

 

IgE mediated cow’s milk allergy n=29

Non-IgE-mediated cow’s milk allergy n=31

Sex, m (%)

20 (69)

24 (77.4)

Age, m (95% CI)

35 (31.0–38.9)

39 (35.7–42.3)

Volume of milk eliciting positive challenge, ml (95% CI)

6 (1.9–10.2)

144.4

Time of onset of reactions, minutes (95 % CI)

48.1 (36.1–60.0)

1843.5 (1618.3–2068.8)

Concomitant multiple food allergies, n (%)

24 (82.7)

23 (74.1)

·Hen’s egg, n (%)

16 (66.7)

5 (21.7)

·Soy, n (%)

3 (12.5)

11 (47.8)

·Peanut, n (%)

10 (41.7)

0

·Wheat, n (%)

5 (20.8)

8 (34.8)

·Tree nut, n (%)

3 (12.5)

0

Gastrointestinal symptoms, n (%)

12 (41.4)

16 (51.6)

·Vomiting, n (%)

9 (31)

11 (35.5)

·Diarrhea, n (%)

4 (13.8)

20 (64.5)

·Hematochezia, n (%)

0

2 (6.4)

Cutaneous symptoms, n (%)

14 (48.3)

8 (2.6)

·Atopic dermatitis, n (%)

10 (71.4)

8 (100)

·Urticaria

4 (28.6)

-

Respiratory symptoms, n (%)

14 (48.3)

0

Anaphylaxis, n (%)

6 (20.7)

0

Positive serum specific IgE to CMP, n (%)

26 (89.6)

0

Positive skin prick test to CMP, n (%)

28 (96.5)

0

Positive atopy patch test to CMP, n (%)

0

27 (87)